---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
webUrl: "https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered"
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: "https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg"
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "oB38m4x6XZZ1IybcKi7Fmch20iWfs5q366tt+vKcePNHIhbPlELRkZIRwL6WUwab5DWBewZIAtpasKmGwruCuU5hyFx1+HN+2/bjX9kLeKt70AF0Wc8YdFnIY6HOI4Zw+qXzmqN4WKbegTffujKlxVl3WZK3X1YqdfCb9SBqz2x8oInksx6fwe0HOrmRgtntH+fV0woSZnWqS9sblTvKyh054Qb3tj3RWqo+Hch7f03WZbSpHbKE+KcN/5FPWh6BriYjGCus7hHCCRUr3DazEYEJ98Qn205lMbEtdjyXbU4EN6F6W5TdxI//7Im79Yni;g//COUTc26vq/AKCEGo4+A=="
---

